Persistence of circulating endothelial microparticles in COPD despite smoking cessation.
Yael Strulovici-Barel, Michelle R Staudt, Anja Krause...
https://pubmed.ncbi.nlm.nih.gov/27462120/Actively Recruiting
Led by Weill Medical College of Cornell University · Updated on 2025-11-14
2000
Participants Needed
1
Research Sites
52 weeks
Total Duration
Researchers are collecting blood, urine, and airway samples from both healthy individuals and those with lung diseases to study genetic expression and other biological factors. The goal is to establish normal ranges for various parameters and compare them with those affected by lung conditions like COPD, IPF, and interstitial lung diseases. This study helps improve understanding of the causes and development of lung diseases by examining changes in airway cells and macrophages before visible disease changes occur. Participants include healthy volunteers and those diagnosed with lung diseases. Samples collected may include blood, urine, nasal and airway brushings, biopsies, or washings. Bronchoscopy is used to gather airway cells in some participants. Clinical patients at certain centers may only provide nasal samples and a small blood sample. All sample collection occurs during separate study visits after informed consent. During the study, participants will provide biological samples and may be followed up with a phone call seven days after their visit. Researchers will analyze genetic material, proteins, and other markers to learn about lung disease causes and progression. The study focuses on comparing data from healthy individuals and lung disease patients, with no additional procedures for some clinical patients. Participation duration varies by visit schedule, and safety is monitored throughout.
CONDITIONS
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
N
Niamh Savage
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Weill Medical College of Cornell University
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Single visit
Participants provide blood, urine, and/or airway specimens including nasal samples, airway brushing, biopsy, and/or washings for research studies.
1 visit (in-person)
Duration - 7 days after sample collection
Participants are followed up by a phone call seven days after their sample collection visit to discuss any concerns or outcomes.
1 follow-up phone call
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Yael Strulovici-Barel, Michelle R Staudt, Anja Krause...
https://pubmed.ncbi.nlm.nih.gov/27462120/Michelle R Staudt, Jacqueline Salit, Robert J Kaner...
https://pubmed.ncbi.nlm.nih.gov/29754582/Weill Medical College of Cornell University
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor